M12-8: MRX34 Biomarker study in animals bearing Hep3B orthotopic liver tumors [Illumina]
收藏官方服务：
资源简介：
M12-8: MRX34 Biomarker study in animals bearing Hep3B orthotopic liver tumors [Illumina]
应用场景：
创建时间：
2014-11-05
相关数据集
Postoperative Serum Levels of sCD26 for Surveillance in Colorectal Cancer Patients
One of the main aims of the follow-up after curative resection of colorectal cancer is the early detection and treatment of tumor recurrence. We previously demonstrated decreased preoperative soluble
Figshare2016-01-15 更新50
Paleturquoise module genes.
Next-generation sequencing technology enables uniform and impartial assessment of cancer diagnoses and prognosis. However, such studies are mostly type-specific, and capturing shared genomic abnormali
Figshare2025-05-30 更新40
Patient characteristics (including Age at diagnosis, Binet stage, Rai stage, IgVH mutation status (um indicates unmutated, m mutated), genomic aberrations such as deletion 11q, deletion 13q14, deletion 17p, trisomy 12, ZAP70 status (pos indicates ZAP70 expression > 20%, neg indicates ZAP70 expression < 20%) (n.d. indicates not done, 1 indicates variable present, 0 indicates variable not present).
Patient characteristics (including Age at diagnosis, Binet stage, Rai stage, IgVH mutation status (um indicates unmutated, m mutated), genomic aberrations such as deletion 11q, deletion 13q14, deletio
NIAID Data Ecosystem20
Artificial neural network identified a 20-gene panel with promising value in predicting immunotherapy response and survival benefits after anti-PD1/PD-L1 treatment in GBM patients
Question: Which biomarker can effectively predict the immunotherapy response and prognostic benefits of GBM patients, and how can potential responders to immune checkpoint inhibitors (ICIs) be disc
Figshare2021-02-25 更新40
BRCAness, SLFN11 and RB1 loss predict response to topoisomerase I inhibitors in triple negative breast cancers. BRCAness, SLFN11 and RB1 loss predict response to topoisomerase I inhibitors in triple negative breast cancers
Expression data from patient-derived xenografts of human triple-negative breast cancers Overall design: We used GeneChip Human 1.1 ST arrays to identify the genes differentially expressed in PDX with
NIAID Data Ecosystem20
